Go Deep
Apyx Medical Corporation
Apyx Medical Corporation Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 13,350 | -12.8 | 10.15 | 3.57 | 244.02 |
| Oct 2026 | 13,379 | -12.8 | 10.11 | 3.57 | 243.10 |
| Oct 2026 | 13,409 | -12.8 | 10.07 | 3.57 | 241.52 |
| Oct 2026 | 13,794 | -12.1 | 9.56 | 3.57 | 229.46 |
| Oct 2026 | 13,735 | -12.2 | 9.64 | 3.57 | 231.35 |
| Oct 2026 | 13,527 | -12.6 | 9.92 | 3.57 | 237.40 |
| Oct 2026 | 13,824 | -12.1 | 9.52 | 3.57 | 227.48 |
Apyx Medical Corporation Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 13,884,000.0 | 12,490,000.0 | 19,164,000.0 | 12,877,000.0 |
| Net Profit | -3,243,000.0 | -2,108,000.0 | -1,299,000.0 | -1,984,000.0 |
| EPS | -0.1 | -0.1 | -0.0 | -0.1 |
Apyx Medical Corporation Revenue & Profit: Last 4 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | 52,844,000.0 | 48,102,000.0 | 52,349,000.0 | 44,510,000.0 |
| Net Profit | -11,211,000.0 | -23,463,000.0 | -18,713,000.0 | -23,184,000.0 |
| EPS | -0.3 | -0.7 | -0.5 | -0.7 |
Apyx Medical Corporation Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 66,840,000.0 | 64,842,000.0 | 79,240,000.0 | 51,775,000.0 | — |
| Total Liabilities | 52,009,000.0 | 50,507,000.0 | 52,318,000.0 | 13,982,000.0 | — |
| Total Equity | 14,540,000.0 | 14,210,000.0 | 26,701,000.0 | 37,582,000.0 | — |
Owes vs Owns
Apyx Medical Corporation owed $0.82 for every $1 it owned in Jun 2026, up from $0.27 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.82× | 0.78× | 0.78× | 0.66× | 0.27× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Apyx Medical Corporation Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 47.5%Receivables 25.1%Inventory 12.9%Fixed assets (tangible) 9.9%Other assets 4.6%
How it's funded — Dec 2025
Short-term debt 0.6%Long-term debt 52.1%Payables 4.6%Other liabilities 20.5%Shareholders' equity 22.2%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 31.7 | 31.7 | 43.7 | 10.2 |
| Receivables | 16.8 | 15.5 | 14.0 | 18.2 |
| Inventory | 8.6 | 7.6 | 9.9 | 11.8 |
| Fixed assets (tangible) | 6.6 | 6.7 | 7.1 | 7.6 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 3.1 | 3.3 | 4.5 | 4.0 |
| Liabilities & equity | ||||
| Short-term debt | 0.4 | 0.4 | 0.4 | 0.3 |
| Long-term debt | 34.8 | 33.9 | 33.2 | 0.5 |
| Payables | 3.1 | 2.6 | 2.7 | 2.7 |
| Other liabilities | 13.7 | 13.6 | 16.1 | 10.5 |
| Shareholders' equity | 14.8 | 14.3 | 26.9 | 37.8 |
| Net tangible assets | 14.5 | 14.2 | 26.7 | 37.6 |
Apyx Medical Corporation Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -8,001,000.0 | -18,047,000.0 | -5,249,000.0 | -20,280,000.0 | — |
| Investing Activities | -1,114,000.0 | -722,000.0 | 6,734,000.0 | -1,010,000.0 | — |
| Financing Activities | 9,580,000.0 | 6,745,000.0 | 32,166,000.0 | 217,000.0 | — |